|
(V1998) |
Subgroup analysis of self-expanding vs balloon-expandable transcatheter aortic valve replacement in Germany |
| |
|
V. Oettinger, I. Hilgendorf, D. Wolf, P. Stachon, K. Kaier, M. Zehender, D. Westermann, C. von zur Mühlen, für die Studiengruppe: CeBAC (Freiburg im Breisgau) |
|
|
Diskussion |
|
(V1999) |
Catheter-based treatment of aortic valve disease in Germany: Indications and temporal trends from a nationwide sample with more than 300,000 cases |
| |
|
M. Linder, P. M. Becher, A. Goßling, T. J. Demal, D. Grundmann, L. Waldschmidt, L. Voigtländer-Buschmann, S. Ludwig, O. Bhadra, J. Schimer, H. Reichenspurner, S. Blankenberg, L. Conradi, N. Schofer, A. Schäfer, M. Seiffert (Hamburg) |
|
|
Diskussion |
|
(V2000) |
Analysis of 2-year survival of aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI): impact of AS subtype and extravalvular cardiac damage in a real-world setting |
| |
|
L. Baez, T. Kräplin, M. Diab, K. Ibrahim, C. Jung, S. Möbius-Winkler, C. Schulze, M. Franz (Jena, Chemnitz, Düsseldorf) |
|
|
Diskussion |
|
(V2001) |
Outcome after transcatheter aortic valve implantation in patients with severe pulmonary hypertension |
| |
|
O. Bhadra, M. Linder, T. J. Demal, S. Ludwig, D. Grundmann, L. Voigtländer-Buschmann, L. Waldschmidt, J. Schirmer, N. Schofer, S. Blankenberg, H. Reichenspurner, L. Conradi, M. Seiffert, A. Schäfer (Hamburg) |
|
|
Diskussion |
|
(V2002) |
Transcatheter aortic valve replacement (TAVR) in low risk patients: real-world data on procedural aspects and outcome |
| |
|
T. Hartikainen, S. Schöchlin, S. Weber, M. Hein, P. Ruile, J. Rilinger, D. Westermann (Bad Krozingen, Freiburg, Freiburg im Breisgau) |
|
|
Diskussion |